Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004
Inhaled formulation of angiotensin-(1-7) produces lung protective effects in a model of chronic asthma. Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Effects of treatment with angiotensin-(1-7) on antigen sensitization of murine experimental model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005
G-CSF administration improves chronic lung disease caused by exposure to high-concentration oxygen in neonatal mice Source: Annual Congress 2012 - Issues in neonatal and paediatric intensive care Year: 2012
Development of inhalation therapy for prevention and treatment of acute lung injury Source: Annual Congress 2010 - Acute respiratory failure Year: 2010
Nevirapine prevent lung injury induced by LPS administration Source: Eur Respir J 2001; 18: Suppl. 33, 197s Year: 2001
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin Source: Eur Respir J 2004; 24: Suppl. 48, 6s Year: 2004
Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs Source: Annual Congress 2010 - Acute respiratory failure Year: 2010
Murine asthma induction: adjuvant and adjuvant-free models produce comparable phenotypes Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008
Human acute lung injury versus the endotoxin model Source: Annual Congress 2008 - Acute lung injury. Do we know what it is? A look at different models Year: 2008
Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Attenuation of acethylcholine and antigen-induced lung parenchyma responsiveness by oral tolerance: a study in a model of chronic airway inflammation in guinea pigs Source: Eur Respir J 2004; 24: Suppl. 48, 350s Year: 2004
Effect of imatinib and nilotinib on lipopolysaccharide-induced acute lung injury during neutropenia recovery in a mouse model Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012
High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003